Sang-Gon Park

556 total citations
42 papers, 264 citations indexed

About

Sang-Gon Park is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sang-Gon Park has authored 42 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sang-Gon Park's work include Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Sang-Gon Park is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Sang-Gon Park collaborates with scholars based in South Korea and France. Sang-Gon Park's co-authors include Hee-Jeong Lee, Hong-Beum Kim, Jun-Won Seo, Jung-Hee Lee, Hyung‐Jin Park, Hyun‐Wook Kim, Jun Hee Park, Ran Hong, Sung Soo Kim and Ting Wu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Sang-Gon Park

38 papers receiving 255 citations

Peers

Sang-Gon Park
Sang-Gon Park
Citations per year, relative to Sang-Gon Park Sang-Gon Park (= 1×) peers Pampa Ch Toi

Countries citing papers authored by Sang-Gon Park

Since Specialization
Citations

This map shows the geographic impact of Sang-Gon Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang-Gon Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang-Gon Park more than expected).

Fields of papers citing papers by Sang-Gon Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang-Gon Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang-Gon Park. The network helps show where Sang-Gon Park may publish in the future.

Co-authorship network of co-authors of Sang-Gon Park

This figure shows the co-authorship network connecting the top 25 collaborators of Sang-Gon Park. A scholar is included among the top collaborators of Sang-Gon Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang-Gon Park. Sang-Gon Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Seul Bi, et al.. (2022). Case mistaken for leukemia after mRNA COVID-19 vaccine administration: A case report. World Journal of Clinical Cases. 10(33). 12268–12277.
2.
Lee, Jung-Hee, Hong-Beum Kim, Jeeho Kim, et al.. (2022). HspBP1 is a dual function regulatory protein that controls both DNA repair and apoptosis in breast cancer cells. Cell Death and Disease. 13(4). 309–309. 8 indexed citations
3.
Lee, Seul Bi, et al.. (2022). Non-secretory multiple myeloma expressed as multiple extramedullary plasmacytoma with an endobronchial lesion mimicking metastatic cancer: A case report. World Journal of Clinical Cases. 10(22). 7899–7905. 1 indexed citations
4.
Go, Se‐Il, Sang‐Cheol Lee, Woo Kyun Bae, et al.. (2021). Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). European Journal of Cancer. 157. 21–30. 17 indexed citations
5.
Kim, Hong-Beum, et al.. (2021). Jagged-1 Expression Level Is Correlated With Recurrence of Stage III Colorectal Cancer in Patients Receiving Adjuvant Chemotherapy. Anticancer Research. 41(9). 4645–4650. 1 indexed citations
6.
Kim, Hong-Beum, et al.. (2020). Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer. Anticancer Research. 40(4). 1897–1904. 8 indexed citations
7.
Yang, Ji Hye, Kyu Min Kim, Sam Seok Cho, et al.. (2019). Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis. Antioxidants and Redox Signaling. 31(3). 243–259. 31 indexed citations
8.
Kim, Hong-Beum, et al.. (2019). Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer. Anticancer Research. 39(11). 6097–6105. 12 indexed citations
9.
Kim, Hong-Beum, et al.. (2019). Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report. World Journal of Clinical Cases. 7(19). 3039–3046. 1 indexed citations
10.
Kim, Hong-Beum, et al.. (2017). Evaluation of the prevalence and clinical impact of toxocariasis in patients with eosinophilia of unknown origin. The Korean Journal of Internal Medicine. 32(3). 523–529. 21 indexed citations
11.
Lee, Hee-Jeong, et al.. (2017). Activation of the coagulation cascade in patients with scrub typhus. Diagnostic Microbiology and Infectious Disease. 89(1). 1–6. 12 indexed citations
12.
Kim, Hong-Beum & Sang-Gon Park. (2017). Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer. World Journal of Gastroenterology. 23(33). 6187–6193. 1 indexed citations
13.
Park, SeonJoo, Hong-Beum Kim, Chunmei Piao, et al.. (2016). p53R2 regulates thioredoxin reductase activity through interaction with TrxR2. Biochemical and Biophysical Research Communications. 482(4). 706–712. 10 indexed citations
14.
Lee, Hee-Jeong, et al.. (2016). Rare complication of bronchoesophageal fistula due to pulmonary mucormycosis after induction chemotherapy for acute myeloid leukemia: a case report. Journal of Medical Case Reports. 10(1). 195–195. 7 indexed citations
15.
16.
Yhim, Ho‐Young, Sang‐Hee Cho, Kyu Taek Lee, et al.. (2015). Prognostic implications of thymidylate synthase gene polymorphisms in patients with advanced small bowel adenocarcinoma treated with first-line fluoropyrimidine-based chemotherapy. Oncology Reports. 34(1). 155–164. 3 indexed citations
17.
Yoon, Youngmin, et al.. (2015). Reactivation of hepatitis B (reverse seroconversion) after melphalan/dexamethasone therapy for primary amyloidosis: a case report. Journal of Medical Case Reports. 9(1). 122–122. 1 indexed citations
18.
Lee, Hee-Jeong, et al.. (2014). Paraneoplastic secondary hypertension due to a renin-secreting desmoplastic small round cell tumor: A case report. Oncology Letters. 8(5). 1986–1992. 13 indexed citations
19.
Park, Sang-Gon, et al.. (2014). 8p11 Myeloproliferative Syndrome with t(1;8)(q25;p11.2): A Case Report and Review of the Literature. Acta Haematologica. 133(1). 101–105. 6 indexed citations
20.
Park, Sang-Gon, et al.. (2011). Spontaneous tumor lysis syndrome with resolution of pancytopenia and disappearance of lymphadenopathy in a patient with peripheral T cell lymphoma unspecified. International Journal of Hematology. 93(3). 394–399. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026